ABXL

ABXL
NYSENONENONE

Key Statistics

Market Cap
P/E Ratio
EPS
Beta
52W High
$26.19
52W Low
$19.07
50-Day MA
$25.82
200-Day MA
$25.35
Dividend Yield
9.47%
Profit Margin
0.00%
Forward P/E
PEG Ratio

About ABXL

ABXL, also known as Abraxas BioScience, is a biopharmaceutical company focused on the development of innovative therapies for serious medical conditions. The company's pipeline consists of proprietary drug candidates aimed at treating diseases with high unmet medical needs, leveraging advanced technologies in drug discovery and development. With a commitment to scientific excellence and regulatory compliance, ABXL is positioned to make significant contributions to the healthcare landscape. Its collaborative approach with academia and industry partners enhances its potential for creating transformative treatments that address critical patient needs.

Official WebsiteUSAFY End: None

Fundamentals

Revenue (TTM)0
Gross Profit (TTM)0
EBITDA
Operating Margin0.00%
Return on Equity0.00%
Return on Assets0.00%
Revenue/Share (TTM)$0.00
Book Value
Price-to-Book
Price-to-Sales (TTM)
EV/Revenue-
EV/EBITDA
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)0.00%
Shares Outstanding0
Float0
% Insiders0.00%
% Institutions0.00%
Data last updated: 4/7/2026